NASDAQ 200 undervalued ranking
Ranked by the Magic Formula (simplified) strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NASDAQ 200 Stocks (2026) →
Best Balanced NASDAQ 200 Stocks (2026) →
💡 Preset screens
Magic Formula (simplified) — Good companies at cheap prices (Greenblatt)
Built from: EV/EBITDA · ROA (Return on Assets)
Past track record (research): ~30.8%/yr
Details →From academic studies of a broad, monthly-rebalanced portfolio — NOT this list of stocks (past data, before fees, possible survivorship bias). The effect weakens over time and is smaller for big companies — a reference, not a promise of these stocks' or future returns.
20 stocks · 19 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1Gilead Sciences Inc.GILD NASDAQ · HealthcareP/E–75.5①
Mkt Cap
$211.8B
P/E
–
P/B
9.3
1M
+17.9%
2United Therapeutics CorporationUTHR NASDAQ · HealthcareP/E21.474.2①
Mkt Cap
$25.7B
P/E
21.4
P/B
4.0
1M
+10.5%
3GE HealthCare Technologies Inc.GEHC NASDAQ · HealthcareP/E16.267.4①
Mkt Cap
$34.6B
P/E
16.2
P/B
3.0
1M
+19.2%
4Amgen Inc.AMGN NASDAQ · HealthcareP/E28.965.0
Mkt Cap
$251.9B
P/E
28.9
P/B
21.6
1M
+15.6%
5Viatris Inc.VTRS NASDAQ · HealthcareP/E–64.8
Mkt Cap
$21.9B
P/E
–
P/B
1.5
1M
+8.2%
6IDEXX Laboratories Inc.IDXX NASDAQ · HealthcareP/E38.763.4
Mkt Cap
$43.4B
P/E
38.7
P/B
27.0
1M
+6.3%
7Biogen Inc.BIIB NASDAQ · HealthcareP/E109.862.9
Mkt Cap
$37.5B
P/E
109.8
P/B
2.0
1M
+15.3%
8DexCom Inc.DXCM NASDAQ · HealthcareP/E32.760.9①
Mkt Cap
$31.1B
P/E
32.7
P/B
11.5
1M
-3.6%
9Medpace Holdings Inc.MEDP NASDAQ · HealthcareP/E36.260.8①
Mkt Cap
$18.2B
P/E
36.2
P/B
31.2
1M
+8.8%
10Alnylam Pharmaceuticals Inc.ALNY NASDAQ · HealthcareP/E27.859.8
Mkt Cap
$22.1B
P/E
27.8
P/B
6.1
1M
-24.9%
11Vertex Pharmaceuticals IncorporatedVRTX NASDAQ · HealthcareP/E32.557.1
Mkt Cap
$141.7B
P/E
32.5
P/B
7.0
1M
+10.7%
12Regeneron Pharmaceuticals Inc.REGN NASDAQ · HealthcareP/E22.955.8
💊 Bio/vaccine
Mkt Cap
$95.5B
P/E
22.9
P/B
3.0
1M
+26.2%
13Genmab A/SGMAB NASDAQ · HealthcareP/E44.950.3①
Mkt Cap
$35.1B
P/E
44.9
P/B
5.7
1M
+64.2%
14Incyte Corp.INCY NASDAQ · HealthcareP/E15.346.6
Mkt Cap
$24.4B
P/E
15.3
P/B
4.3
1M
+4.4%
15Medline Inc.MDLN NASDAQ · HealthcareP/E80.345.7
Mkt Cap
$43.2B
P/E
80.3
P/B
2.4
1M
-9.8%
16Royalty Pharma plcRPRX NASDAQ · HealthcareP/E35.742.3①
Mkt Cap
$38.8B
P/E
35.7
P/B
4.4
1M
+17.5%
17Illumina Inc.ILMN NASDAQ · HealthcareP/E44.042.2
Mkt Cap
$35.6B
P/E
44.0
P/B
13.3
1M
-13.6%
18BeOne Medicines Ltd.ONC NASDAQ · HealthcareP/E66.239.9
Mkt Cap
$42.1B
P/E
66.2
P/B
8.1
1M
+3.4%
19argenx SEARGX NASDAQ · HealthcareP/E30.9–①
Mkt Cap
$56.1B
P/E
30.9
P/B
165.8
1M
-2.9%
20Clover Health Investments Corp.CLOV NASDAQ · HealthcareP/E––①
Mkt Cap
$2.4B
P/E
–
P/B
6.3
1M
+1.8%